CTLA-4 overexpression in CD19+/CD5+ cells correlates with the level of cell cycle regulators and disease progression in B-CLL patients

Leukemia. 2005 Feb;19(2):301-4. doi: 10.1038/sj.leu.2403588.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD / blood
  • Antigens, CD19 / blood*
  • Antigens, Differentiation / blood*
  • Antigens, Differentiation / genetics
  • B-Lymphocytes / immunology*
  • B-Lymphocytes / pathology
  • CD5 Antigens / blood
  • CTLA-4 Antigen
  • Cell Cycle / immunology*
  • Disease Progression
  • Exons
  • Female
  • Genotype
  • Humans
  • Immunoglobulin Fc Fragments / blood
  • Immunoglobulin Fc Fragments / genetics
  • Leukemia, B-Cell / blood
  • Leukemia, B-Cell / immunology*
  • Male
  • Promoter Regions, Genetic
  • Reference Values
  • T-Lymphocytes, Cytotoxic / immunology

Substances

  • Antigens, CD
  • Antigens, CD19
  • Antigens, Differentiation
  • CD5 Antigens
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Immunoglobulin Fc Fragments